Nov. 4 Company Quick Takes: FDA approves RedHill’s antibiotic; plus NiKang, Revolution-Amgen, Aveo and Tmunity-Oncora

RedHill gets FDA approval for antibiotic
FDA approved Talicia from RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL) to treat Helicobacter pylori infection in adults. RedHill plans to launch the fixed-dose combination of rifabutin,

Read the full 314 word article

How to gain access

Continue reading with a
two-week free trial.